Skip to main content

Table 1 Baseline characteristics of the study population

From: Inverse association between plasma chlordecone concentrations and progression of alcoholic liver fibrosis: the role of liver metabolism

Characteristics

N (%)

Number of patients

182

Age at enrolment (mean, SD)

53.7 (11.6)

Sex

 

 Men

162 (89.0)

 Women

20 (11.0)

Education

 

 Primary

42 (23.1)

 Secondary

117 (64.3)

 High School and higher

23 (12.6)

Body mass Index, kg/m2

 

 Normal (< 25)

139 (76.4)

 Overweight (25 – <30)

37 (20.3)

 Obesity ( 30)

6 (3.3)

Weight loss > 10% during the last 10 years

 

 No

143 (78.6)

 Yes

39 (21,4)

Alcohol consumption *, g/day (median)

165

Alcohol consumption *, g/day

 

 < 50

18 (9.9)

50

164 (90,1)

Age at alcohol onset, years

 

 < 40

167 (91.8)

 > 40

15 (8.2)

Smoking

 

 Never

97 (53.3)

 Ever

85 (46.7)

Coffee consumption

 

 Never

102 (56.0)

 Ever

88 (44.0)

Recreational drugs

 

 Never

169 (92.9)

 Ever

13 (7.1)

Diabetes type 2

 

 No

160 (87.9)

 Yes

22 (12.1)

HBV coinfection

 

 No

174 (95.6)

 Yes

8 (4.4)

HCV coinfection

 

 No

169 (92.9)

 Yes

13 (7.1)

Fibrosis stage

 

 No fibrosis (F0)

45 (24.7)

 Fibrosis without septa (F1)

8 (4.4)

 Few septa (F2)

11 (6.0)

 Many septa (F3)

6 (3.3)

 Cirrhosis (F4)

112 (61.5)

 Follow-up time, years (mean, SD)

27.1 (13.4)

  1. *As pure ethanol equivalent